These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 12203394)

  • 1. Matrix metalloproteinases in neuroinflammation.
    Rosenberg GA
    Glia; 2002 Sep; 39(3):279-91. PubMed ID: 12203394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical implications of matrix metalloproteinases.
    Mandal M; Mandal A; Das S; Chakraborti T; Sajal C
    Mol Cell Biochem; 2003 Oct; 252(1-2):305-29. PubMed ID: 14577606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diverse roles of matrix metalloproteinases and tissue inhibitors of metalloproteinases in neuroinflammation and cerebral ischemia.
    Candelario-Jalil E; Yang Y; Rosenberg GA
    Neuroscience; 2009 Feb; 158(3):983-94. PubMed ID: 18621108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
    Rosenberg GA
    Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.
    Raeeszadeh-Sarmazdeh M; Do LD; Hritz BG
    Cells; 2020 May; 9(5):. PubMed ID: 32466129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple roles for MMPs and TIMPs in cerebral ischemia.
    Cunningham LA; Wetzel M; Rosenberg GA
    Glia; 2005 Jun; 50(4):329-339. PubMed ID: 15846802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple roles of metalloproteinases in neurological disorders.
    Yang Y; Hill JW; Rosenberg GA
    Prog Mol Biol Transl Sci; 2011; 99():241-63. PubMed ID: 21238938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinases in cerebrovascular disease.
    Mun-Bryce S; Rosenberg GA
    J Cereb Blood Flow Metab; 1998 Nov; 18(11):1163-72. PubMed ID: 9809504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.
    Romanic AM; White RF; Arleth AJ; Ohlstein EH; Barone FC
    Stroke; 1998 May; 29(5):1020-30. PubMed ID: 9596253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain.
    Gasche Y; Soccal PM; Kanemitsu M; Copin JC
    Front Biosci; 2006 May; 11():1289-301. PubMed ID: 16368516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases.
    Siasos G; Tousoulis D; Kioufis S; Oikonomou E; Siasou Z; Limperi M; Papavassiliou AG; Stefanadis C
    Curr Top Med Chem; 2012; 12(10):1132-48. PubMed ID: 22519444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.
    Maskos K; Bode W
    Mol Biotechnol; 2003 Nov; 25(3):241-66. PubMed ID: 14668538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix Metalloproteinases: How Much Can They Do?
    Ågren MS; Auf dem Keller U
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32290531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat.
    Amantea D; Russo R; Gliozzi M; Fratto V; Berliocchi L; Bagetta G; Bernardi G; Corasaniti MT
    Int Rev Neurobiol; 2007; 82():149-69. PubMed ID: 17678960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous and synthetic MMP inhibitors in CNS physiopathology.
    Baranger K; Rivera S; Liechti FD; Grandgirard D; Bigas J; Seco J; Tarrago T; Leib SL; Khrestchatisky M
    Prog Brain Res; 2014; 214():313-51. PubMed ID: 25410364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives.
    Beaudeux JL; Giral P; Bruckert E; Foglietti MJ; Chapman MJ
    Clin Chem Lab Med; 2004 Feb; 42(2):121-31. PubMed ID: 15061349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MMPs and ADAMs in neurological infectious diseases and multiple sclerosis.
    Muri L; Leppert D; Grandgirard D; Leib SL
    Cell Mol Life Sci; 2019 Aug; 76(16):3097-3116. PubMed ID: 31172218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia.
    Rosenberg GA; Yang Y
    Neurosurg Focus; 2007 May; 22(5):E4. PubMed ID: 17613235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.